Triangulate is a company.
Key people at Triangulate.
Triangulate was founded by Sunil Nagaraj (Founder/CEO) and David Chen (Co-founder, VP Product).
Triangulate was founded by Sunil Nagaraj (Founder/CEO) and David Chen (Co-founder, VP Product).
Key people at Triangulate.
Triangulate Labs is an AI and computer vision startup developing Skinmap, a total body photography (TBP) system that helps dermatologists detect skin cancer and track skin lesions more accurately.[1][7] The product captures hundreds of high-resolution images using a mobile device in under 60 seconds, employs a patented nonlinear optimization algorithm to map pixels onto a 3D skin avatar, and highlights changes via a blink comparator for easier visualization.[1][7] It serves dermatologists and aims to expand to primary care physicians, addressing gaps for the 50 million US patients without local dermatologist access, who face double the skin cancer mortality risk.[1] Founded in 2022 in Boynton Beach, Florida, the three-person team is gaining momentum through a Mayo Clinic know-how license (May 2024) to enhance clinical workflows and remote care.[7]
Triangulate Labs was founded in 2022 by a small team including Dr. William Hall, who serves as co-founder and emphasizes the need for accessible skin cancer detection.[1][7] The idea emerged from advances in dynamic computer vision and AI, targeting healthcare inefficiencies in skin monitoring, particularly for underserved populations.[1] A pivotal moment came in March 2024 with a patent for their AI system that aligns multi-angle photos into a precise 3D baseline for tracking changes over time.[1] Early traction includes the Mayo Clinic collaboration announced May 28, 2024, providing expertise in TBP, AI medical devices, and care for remote patients to accelerate Skinmap's development.[7]
Triangulate Labs rides the AI-driven medical imaging wave, where computer vision enhances diagnostics amid rising skin cancer rates and clinician shortages.[1][7] Timing aligns with post-2020 AI adoption in healthcare, accelerated by mobile tech and telehealth post-pandemic, plus growing emphasis on preventive care for aging populations.[1] Market forces like the US's 50 million dermatology deserts favor scalable, low-cost tools like Skinmap, which democratizes TBP beyond high-end clinics.[1] It influences the ecosystem by pushing AI from research to routine practice, potentially setting standards for remote skin monitoring and inspiring similar tools in other fields like oncology.[7]
Triangulate Labs is poised to scale Skinmap into more clinics via Mayo Clinic enhancements, targeting primary care expansion and FDA pathways for broader adoption.[1][7] Trends like AI regulatory approvals, tele-dermatology growth, and personalized medicine will propel it, with potential for global reach in underserved regions. Its influence may evolve from niche innovator to ecosystem shaper, redefining early skin cancer detection as routine and equitable—ultimately saving lives where access has long been the barrier.[1][7]
